Details for New Drug Application (NDA): 018513
✉ Email this page to a colleague
NDA 018513 describes CHENIX, which is a drug marketed by Leadiant Biosci Inc and is included in one NDA. Additional details are available on the CHENIX profile page.
The generic ingredient in CHENIX is chenodiol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the chenodiol profile page.
The generic ingredient in CHENIX is chenodiol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the chenodiol profile page.
Summary for 018513
| Tradename: | CHENIX |
| Applicant: | Leadiant Biosci Inc |
| Ingredient: | chenodiol |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 28, 1983 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
